Skip to main content
. 2021 Apr 12;12:659625. doi: 10.3389/fimmu.2021.659625

Figure 2.

Figure 2

Diversity TCR metrics in MDS patients prior to and following treatment with hypomethylating agents. (A) Richness and (B) rarefaction analysis in all patients and by response groups. (C) Simpson clonality index as measurement of degree of clonality. (D) Relative abundance of the different clonotype groups based on the frequency of clonotype. (E) Barplot representation of the relative abundance measurements in (D).